Business Description
MediClin AG
ISIN : DE0006595101
Total Employee Number:
7,048Compare
Compare
Traded in other countries / regions
MED.Germany0NDG.UK Description
MediClin AG operates hospitals and other medical care centers. The company's reportable operating segments are the Post-acute, Acute, Nursing care, and Service segments. A majority of its revenue is generated from the Post-acute segment, which offers services in the fields of follow-up rehabilitation treatment and curative treatment. Some of the post-acute hospitals also offer services in acute neurology and acute psychosomatics. The Acute segment encompasses medical offerings with a focus on neurology and neurological early rehabilitation as well as psychosomatic medicine, psychiatry, orthopaedics, and internal medicine. The Nursing care segment offers full-time and part-time nursing care as well as daycare, and the Service segment consists of the central services.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.41 | |||||
Equity-to-Asset | 0.3 | |||||
Debt-to-Equity | 1.46 | |||||
Debt-to-EBITDA | 3.04 | |||||
Interest Coverage | 2.92 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 1.62 | |||||
Beneish M-Score | -3 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.6 | |||||
3-Year EBITDA Growth Rate | 8.6 | |||||
3-Year EPS without NRI Growth Rate | 39.2 | |||||
3-Year FCF Growth Rate | 81 | |||||
3-Year Book Growth Rate | 6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 17.55 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 2.57 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 68.47 | |||||
9-Day RSI | 58.96 | |||||
14-Day RSI | 57.51 | |||||
3-1 Month Momentum % | 21.21 | |||||
6-1 Month Momentum % | 16.28 | |||||
12-1 Month Momentum % | 37.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.74 | |||||
Quick Ratio | 1.7 | |||||
Cash Ratio | 0.91 | |||||
Days Inventory | 20.22 | |||||
Days Sales Outstanding | 41.27 | |||||
Days Payable | 32.19 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.02 | |||||
Dividend Payout Ratio | 0.07 | |||||
Forward Dividend Yield % | 1.02 | |||||
5-Year Yield-on-Cost % | 1.03 | |||||
Shareholder Yield % | 28.66 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 84.84 | |||||
Operating Margin % | 7.92 | |||||
Net Margin % | 3.71 | |||||
EBITDA Margin % | 15.47 | |||||
FCF Margin % | 6.12 | |||||
OCF Margin % | 12.26 | |||||
ROE % | 12.11 | |||||
ROA % | 3.33 | |||||
ROIC % | 6.74 | |||||
3-Year ROIIC % | -22.02 | |||||
ROC (Joel Greenblatt) % | 11.81 | |||||
ROCE % | 8.61 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 6.66 | |||||
Forward PE Ratio | 4.64 | |||||
PE Ratio without NRI | 6.66 | |||||
Shiller PE Ratio | 20.41 | |||||
Price-to-Owner-Earnings | 4.18 | |||||
PEG Ratio | 0.79 | |||||
PS Ratio | 0.25 | |||||
PB Ratio | 0.77 | |||||
Price-to-Tangible-Book | 0.82 | |||||
Price-to-Free-Cash-Flow | 3.92 | |||||
Price-to-Operating-Cash-Flow | 1.99 | |||||
EV-to-EBIT | 6.7 | |||||
EV-to-EBITDA | 3.38 | |||||
EV-to-Revenue | 0.52 | |||||
EV-to-FCF | 8.5 | |||||
Price-to-GF-Value | 1.34 | |||||
Price-to-Projected-FCF | 0.29 | |||||
Price-to-DCF (Earnings Based) | 0.19 | |||||
Price-to-DCF (FCF Based) | 0.3 | |||||
Price-to-Median-PS-Value | 0.85 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.63 | |||||
Price-to-Graham-Number | 0.49 | |||||
Earnings Yield (Greenblatt) % | 14.92 | |||||
FCF Yield % | 24.94 | |||||
Forward Rate of Return (Yacktman) % | 30.76 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MediClin AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 786.541 | ||
| EPS (TTM) (€) | 0.61 | ||
| Beta | 0.6095 | ||
| 3-Year Sharpe Ratio | 0.35 | ||
| 3-Year Sortino Ratio | 0.67 | ||
| Volatility % | 24.31 | ||
| 14-Day RSI | 57.51 | ||
| 14-Day ATR (€) | 0.133877 | ||
| 20-Day SMA (€) | 3.892 | ||
| 12-1 Month Momentum % | 37.93 | ||
| 52-Week Range (€) | 2.8 - 4.22 | ||
| Shares Outstanding (Mil) | 47.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
MediClin AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
MediClin AG Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| EUR 0.040000 Cash Dividend | 2026-05-29 | 3.64 (+0.00%) | ||
| EUR 0.040000 Cash Dividend | 2025-06-05 | 2.88 (-0.69%) |
Show
Entries
MediClin AG Frequently Asked Questions
What is MediClin AG(STU:MED)'s stock price today?
The current price of STU:MED is €3.92. The 52 week high of STU:MED is €4.22 and 52 week low is €2.80.
When is next earnings date of MediClin AG(STU:MED)?
The next earnings date of MediClin AG(STU:MED) is .
Does MediClin AG(STU:MED) pay dividends? If so, how much?
The Dividend Yield %  of MediClin AG(STU:MED) is 1.02% (As of Today), Highest Dividend Payout Ratio of MediClin AG(STU:MED) was 0.31. The lowest was 0.07. And the median was 0.25. The  Forward Dividend Yield % of MediClin AG(STU:MED) is 1.02%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on MediClin AG
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers